Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739167 · ClinicalTrials.gov registry record
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 74
- Enrollment target
NCT00739167 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 74 participants.
The verdict
NCT00739167 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
RATIONALE: Learning about quality of life in patients with cancer undergoing embolization may help doctors learn about the side effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying quality of life in patients undergoing embolization using yttrium Y 90 glass microspheres for primary or metastatic liver cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00739167
The ClinicalTrials.gov registry entry for NCT00739167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00739167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00739167 about?
NCT00739167 is a clinical study titled "Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer". RATIONALE: Learning about quality of life in patients with cancer undergoing embolization may help doctors learn about the side effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying quality of life in patients undergoing embolization using yttrium Y 90 glass mic...
What is the current status of trial NCT00739167?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2008-04. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT00739167?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.